TBC1D13
TBC1 domain family member 13
Also known as: FLJ10743, TBC13_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NVG8
- Gene
- TBC1D13
- Ensembl
- ENSG00000107021
- Chromosome
- 9
- Canonical length
- 400 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Predicted to enable GTPase activator activity. Predicted to be involved in intracellular protein transport. Predicted to be located in cytosol and membrane. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
400 residues, UniProt reviewed canonical sequence.
>Q9NVG8|TBC1D13
1 MSSLHKSRIA DFQDVLKEPS IALEKLRELS FSGIPCEGGL RCLCWKILLN YLPLERASWT
61 SILAKQRELY AQFLREMIIQ PGIAKANMGV SREDVTFEDH PLNPNPDSRW NTYFKDNEVL
121 LQIDKDVRRL CPDISFFQRA TDYPCLLILD PQNEFETLRK RVEQTTLKSQ TVARNRSGVT
181 NMSSPHKNSV PSSLNEYEVL PNGCEAHWEV VERILFIYAK LNPGIAYVQG MNEIVGPLYY
241 TFATDPNSEW KEHAEADTFF CFTNLMAEIR DNFIKSLDDS QCGITYKMEK VYSTLKDKDV
301 ELYLKLQEQN IKPQFFAFRW LTLLLSQEFL LPDVIRIWDS LFADDNRFDF LLLVCCAMLM
361 LIREQLLEGD FTVNMRLLQD YPITDVCQIL QKAKELQDSKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TBC1D13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- amygdala: 32 nTPM
- cerebral cortex: 32 nTPM
- kidney: 28 nTPM
- hippocampal formation: 28 nTPM
- parathyroid gland: 27 nTPM
- hypothalamus: 25 nTPM
Single-cell type
- oligodendrocytes: 48 nCPM
- proximal tubule cells: 42 nCPM
- myonuclei: 40 nCPM
- hofbauer cells: 36 nCPM
- platelets: 30 nCPM
- megakaryocytes: 25 nCPM
Immune cell
- basophil: 23 nTPM
- plasmacytoid DC: 8.4 nTPM
- naive CD8 T-cell: 5 nTPM
- eosinophil: 4.8 nTPM
- memory B-cell: 4.7 nTPM
- MAIT T-cell: 4.4 nTPM
Brain region
- amygdala: 43 nTPM
- cerebral cortex: 40 nTPM
- pons: 38 nTPM
- medulla oblongata: 38 nTPM
- hypothalamus: 38 nTPM
- white matter: 37 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.73
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.79
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TBC1D13 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TBC1D13 as an antibody target. Whether an autoantibody or antibody against TBC1D13 could matter depends on whether native TBC1D13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TBC1D13 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TBC1D13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...